Advantage Biotech Market Intelligence 
Alpha Sense BI
FEBRUARY 8, 2023
Specifically, within the pharma and biotech sectors, there have been 22 deals announced so far in 2023 — again, a low number compared to the 70 made over the same period last year. Additionally, unprofitable biopharma, aka most biotech companies, is expected to invest $1.1 Sign up for your free trial today.
Alpha Sense BI
AUGUST 30, 2023
As time goes on and more firms adopt AI tools, these capabilities will become even more essential to maintain a competitive advantage. Research shows that the AI in asset management market will grow at a staggering 34% CAGR through 2027. Artificial intelligence is the only way to do it.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Alpha Sense BI
MAY 28, 2024
Below, we explore the factors constraining venture capital funding into the first half of the year, and the ways investors can leverage crucial market intelligence to gain a competitive advantage in the shifting landscape. Investors funded $76 billion in the period, their lowest since the second quarter of 2019.
Alpha Sense BI
MARCH 28, 2023
The Value: AlphaSense is an AI-powered search engine for market intelligence. And with Stream in AlphaSense, users can leverage expert perspectives against insights derived from our extensive and ever-growing universe of content, gaining a 360 view on any market, industry, or trend. Who uses expert networks?
Alpha Sense BI
APRIL 12, 2024
AlphaSense, a leading artificial intelligence (AI)-based market intelligence platform , offers proprietary Expert Insights through its extensive expert transcript library and Expert Call Services. That expert call may be one of the single advantages in the stack.
Alpha Sense BI
JUNE 6, 2024
Whether you’re looking to refine your market strategy, innovate more effectively, or enhance your competitive advantage, mastering competitor analysis is your key to sustained success and growth. AlphaSense provides best-in-class AI features that truly move the needle for our customers and give them the biggest advantage.
Alpha Sense BI
JANUARY 25, 2023
Moderna and BioTech, the pharmaceuticals companies behind the Moderna vaccines for the COVID-19 virus, just announced a new treatment this past December that would greatly reduce the chances of death from melanoma — stirring up substantial interest in investors to funnel capital. a potential cure for skin cancer.
Expert insights. Personalized for you.
96 
Let's personalize your content